NBY Insider Trading Activity and SEC Form 4 Filings
NBY insider trading summary
No open-market insider purchases or sales of NovaBay Pharmaceuticals, Inc. (NBY) have been reported on SEC Form 4 in the past 12 months.
Latest NBY insider buys and sells
| Date | Insider | Role | Type | Value |
|---|---|---|---|---|
| Apr 8, 2025 | Poplar Point Capital Management LLC | 10% Owner | Buy | $140 (300 @ $0.47) |
| Apr 8, 2025 | Poplar Point Capital Partners LP | 10% Owner | Buy | $140 (300 @ $0.47) |
| Apr 8, 2025 | Poplar Point Capital Gp LLC | 10% Owner | Buy | $140 (300 @ $0.47) |
| Apr 8, 2025 | Jad Fakhry | 10% Owner | Buy | $140 (300 @ $0.47) |
| Apr 4, 2025 | Jad Fakhry | 10% Owner | Buy | $2K (4,538 @ $0.52) |
| Apr 4, 2025 | Poplar Point Capital Gp LLC | 10% Owner | Buy | $2K (4,538 @ $0.52) |
| Apr 4, 2025 | Poplar Point Capital Management LLC | 10% Owner | Buy | $2K (4,538 @ $0.52) |
| Apr 4, 2025 | Poplar Point Capital Partners LP | 10% Owner | Buy | $2K (4,538 @ $0.52) |
| Apr 3, 2025 | Poplar Point Capital Management LLC | 10% Owner | Buy | $13K (22,976 @ $0.56) |
| Apr 3, 2025 | Jad Fakhry | 10% Owner | Buy | $13K (22,976 @ $0.56) |
Source: SEC Form 4 filings. Open-market purchases (code P) and sales (code S) only; option exercises, grants and gifts are excluded.